Idiopathic Generalized Epilepsy: Clinical Trials

3 trials for Idiopathic Generalized Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Not yet recruiting 1

Follow Idiopathic Generalized Epilepsy: new trials by email Literature Review of Idiopathic Generalized Epilepsy trials Research Report on Idiopathic Generalized Epilepsy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years
Intervention 1, Intervention 2 - Idiopathic Generalized Epilepsy
Not applicableNot yet recruitingOregon Health and Science University102027-02-012026-09-04
RNS System NAUTILUS Study
Responsive stimulation, Sham stimulation - Epilepsy, Idiopathic Generalized Epilepsy
Not applicableCompletedNeuroPace1002022-08-092026-06-08
Blinking and Yawning in Epilepsy: The Role of Dopamine
Apomorphine (Experimental product) - Idiopathic Generalized Epilepsy
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France312011-09-012026-02-18

Narrower conditions

Epilepsy (3)  ·  Epilepsy, Idiopathic Generalized (3)  ·  Epilepsy, Generalized (1)  ·  Epilepsy, Tonic-Clonic (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Epilepsy, Generalized (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Apomorphine (1)

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  NeuroPace (1)  ·  Oregon Health and Science University (1)

Countries

United States (2)  ·  France (1)

Top investigators

Ahmed Raslan, MD (1)  ·  Martha Morrell, MD (1)